Related Experiment Video

Updated: May 21, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Integrin-linked kinase is dispensable for multiple myeloma cell survival

Torsten Steinbrunn1, Daniela Siegmund, Mindaugas Andrulis

  • 1Department of Internal Medicine II, Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.

Leukemia Research
|June 5, 2012
PubMed

Insights

Integrin-linked kinase (ILK) is not a viable therapeutic target for multiple myeloma (MM). While ILK is present in MM cells, inhibiting it did not affect cell viability, contrary to expectations for MM treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Integrin-linked kinase (ILK) plays a role in various cellular processes, including cell survival and proliferation.
  • Its potential as a therapeutic target in multiple myeloma (MM) remains to be fully elucidated.
  • Assessing ILK's role is crucial for developing novel MM treatment strategies.

Purpose of the Study:

  • To investigate the therapeutic potential of targeting integrin-linked kinase (ILK) in multiple myeloma (MM).
  • To evaluate the effects of ILK inhibition on MM cell viability and survival pathways.
  • To compare the efficacy of siRNA-mediated ILK ablation with a small molecule inhibitor (QLT0267).

Main Methods:

  • Assessed ILK expression in primary MM patient samples and MM cell lines.
  • Utilized siRNA to ablate ILK expression in MM cells.
  • Treated MM cell lines and primary samples with the small molecule inhibitor QLT0267.
  • Analyzed cell viability and apoptotic pathway activation.

Main Results:

  • ILK expression was ubiquitous in MM, but overexpression was rare in patient biopsies.
  • ILK knockdown did not impact MM cell viability or survival pathways.
  • QLT0267 induced cell death in MM cell lines and most primary samples via the intrinsic apoptotic pathway.
  • The cell death induced by QLT0267 was largely tumor cell-specific but unlikely mediated through ILK.

Conclusions:

  • Integrin-linked kinase (ILK) does not appear to be a significant factor in the development or maintenance of established multiple myeloma.
  • The small molecule inhibitor QLT0267 exhibits anti-myeloma activity, but its mechanism is likely independent of ILK inhibition.
  • Further research is needed to identify the precise mechanism of QLT0267 and validate other therapeutic targets in MM.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...